Cited by 1,360Ovarian function and disordersDiabetes, Cardiovascular Risks, and LipoproteinsGenetic and Kidney Cyst Diseases

The DOI matches its Crossref record; 179 of the 181 references it cites were found in a registry or an index.

Polycystic ovary syndrome

Norman, Robert J, Dewailly, Didier, Legro, Richard S, Hickey, Theresa E·2007·The Lancet

DOI 10.1016/s0140-6736(07)61345-2

Open this paper in CoChat — free account

Abstract

Polycystic ovary syndrome is a heterogeneous endocrine disorder that affects about one in 15 women worldwide. The major endocrine disruption is excessive androgen secretion or activity, and a large proportion of women also have abnormal insulin activity. Many body systems are affected in polycystic ovary syndrome, resulting in several health complications, including menstrual dysfunction, infertility, hirsutism, acne, obesity, and metabolic syndrome. Women with this disorder have an established increased risk of developing type 2 diabetes and a still debated increased risk of cardiovascular disease. The diagnostic traits of polycystic ovary syndrome are hyperandrogenism, chronic anovulation, and polycystic ovaries, after exclusion of other conditions that cause these same features. A conclusive definition of the disorder and the importance of the three diagnostic criteria relative to each other remain controversial. The cause of polycystic ovary syndrome is unknown, but studies suggest a strong genetic component that is affected by gestational environment, lifestyle factors, or both.

Integrity signals

Registry

Crossref · 10.1016/s0140-6736(07)61345-2

Cites

179 of 179 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011
The metabolic syndrome—a new worldwide definition
Alberti, K. G. M., Zimmet, P., & Shaw, J. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67402-8 · Cited by 9,352
Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome
(2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2003.10.004 · Cited by 9,050
Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)
The Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group (2004) · Human Reproduction · doi:10.1093/humrep/deh098 · Cited by 6,138
A Critical Evaluation of Simple Methods for the Estimation of Free Testosterone in Serum
Vermeulen, A., Verdonck, L., & Kaufman, J. M. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.10.6079 · Cited by 3,824
Insulin Resistance and the Polycystic Ovary Syndrome: Mechanism and Implications for Pathogenesis
Dunaif, A. E. (1997) · Endocrine Reviews · doi:10.1210/edrv.18.6.0318 · Cited by 2,776
The Prevalence and Features of the Polycystic Ovary Syndrome in an Unselected Population
Azziz, R., Woods, K. S., Reyna, R., Key, T. J., Knochenhauer, E. S., & Yıldız, B. O. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-032046 · Cited by 2,715
Clinical assessment of body hair growth in women.
Ferriman, D., & Gallwey, J. D. (1961) · Journal of Clinical Endocrinology and Metabolism · doi:10.1210/jcem-21-11-1440 · Cited by 2,556
Criteria for Defining Polycystic Ovary Syndrome as a Predominantly Hyperandrogenic Syndrome: An Androgen Excess Society Guideline
Azziz, R., Carmina, E., Dewailly, D., Diamanti-Kandarakis, E., Escobar-Morreale, H. F., Futterweit, W., Janssen, O. E., Legro, R. S., Norman, R. J., Taylor, A. E., et al. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0178 · Cited by 2,143
Self-citation
Amenorrhea associated with bilateral polycystic ovaries
Stein, I. F., & Leventhal, M. L. (1935) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(15)30642-6 · Cited by 2,121

Show all 181 references

Research works printed but not linked: 5

Azziz, 2006, Criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an androgen excess Society guideline, J Clin Endocrinol Metab, 91, 4237, 10.1210/jc.2006-0178 · DOI · Paper page
Legro, 1999, Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women, J Clin Endocrinol Metab, 84, 165
Legro, 2006, Pregnancy in polycystic ovary syndrome (PPCOS) baseline characteristics: effect of race and ethnicity on the PCOS phenotype, J Soc Gynecol Investig, 13, 268a
van Vloten, 2002, The effect of 2 combined oral contraceptives containing either drospirenone or cyproterone acetate on acne and seborrhea, Cutis, 69, 2
Hughes, 2000, Gonadotrophin-releasing hormone analogue as an adjunct to gonadotropin therapy for clomiphene-resistant polycystic ovarian syndrome, Cochrane Database Syst Rev, 2

Sorted by citations

Items 801–900 of 1,000

Mfn2 regulates mitochondria-associated ER membranes to affect PCOS oocyte development
Liao, X., Zhu, S., Qiu, S., Cao, H., Jiang, W., Xu, H., Sun, Y., & Zheng, B. (2023) · Endocrine Connections · doi:10.1530/ec-23-0343 · Cited by 11
Bacterial Vaginosis (BV) and Vaginal Microbiome Disorders in Women Suffering from Polycystic Ovary Syndrome (PCOS)
Chudzicka-Strugała, I., Gołębiewska, I., Banaszewska, B., Trzcinski, M., Brudecki, G. P., Elamin, W. F., & Zwoździak, B. (2024) · Diagnostics · doi:10.3390/diagnostics14040404 · Cited by 14
Risk of polycystic ovary syndrome: a population-based analysis of sociodemographic factors, healthcare access, health behaviors, and health status
Alenzi, E. O., Alqntash, N., Almajed, E. H., & AlZabin, A. K. (2024) · BMC Women s Health · doi:10.1186/s12905-024-03446-9 · Cited by 15
The Role of Exosomes in Diseases Related to Infertility
Jiayu, H., Zhang, H., & Gao, Y. (2019) · Current Stem Cell Research & Therapy · doi:10.2174/1574888x14666190123162842 · Cited by 11
Genetic polymorphisms associated with polycystic ovary syndrome among Iranian women
Jamshidi, M., Pour, S. M., Bahadoram, M., Mahmoudian‐Sani, M., & Saeedi‐Boroujeni, A. (2020) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.13534 · Cited by 12
Molecular docking and pharmacology study to explore bio-active compounds and underlying mechanisms of Caesalpinia bonducella on polycystic ovarian syndrome
Hossain, M. A., Sharfaraz, A., Hasan, M. I., Somadder, P. D., Haque, M. A., Sarker, M. R., Alam, M. M., Hasan, A. M. W., Sohel, M. M. H., & Rahman, M. H. (2022) · Informatics in Medicine Unlocked · doi:10.1016/j.imu.2022.101073 · Cited by 11
Association between immunity and different clinical symptoms in patients with polycystic ovary syndrome
Xiao, H., Yin, T., Diao, L., Zhang, Y., & Huang, C. (2023) · American Journal of Reproductive Immunology · doi:10.1111/aji.13780 · Cited by 11
Correlation between chronic low-grade inflammation and glucose and lipid metabolism indicators in polycystic ovary syndrome
Zhou, Y., Wang, X., Guo, S., Li, R., Li, Y., Yu, Y., & Liu, T. H. (2024) · Gynecological Endocrinology · doi:10.1080/09513590.2024.2302402 · Cited by 12
Association between rs7903146 and rs12255372 polymorphisms of transcription factor 7-like 2 gene and polycystic ovary syndrome: a systematic review and meta-analysis
Ramos, R. B., Fabris, V. C., Brondani, L. D. A., & Spritzer, P. M. (2015) · Endocrine · doi:10.1007/s12020-015-0541-x · Cited by 11
Abnormal CFTR Affects Glucagon Production by Islet α Cells in Cystic Fibrosis and Polycystic Ovarian Syndrome
Huang, W. Q., Guo, J. H., Yuan, C., Cui, Y. G., Diao, F., Yu, M., Liu, J. Y., Ruan, Y. C., & Chan, H. C. (2017) · Frontiers in Physiology · doi:10.3389/fphys.2017.00835 · Cited by 11
Elevated levels of the circulatory ischemia-modified albumin in patients with polycystic ovary syndrome: a meta-analysis
Varikasuvu, S. R., Bukke, S., & Munikumar, M. (2018) · Gynecological Endocrinology · doi:10.1080/09513590.2018.1462318 · Cited by 11
Cardiovascular profile of pharmacological agents used for the management of polycystic ovary syndrome
Alalami, H., Sathyapalan, T., & Atkin, S. L. (2018) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018818805674 · Cited by 12
Creatine Kinase Is a Marker of Metabolic Syndrome in Qatari Women With and Without Polycystic Ovarian Syndrome
Al-Hail, N., Butler, A. E., Dargham, S. R., Seif, A. A., & Atkin, S. L. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00659 · Cited by 11
Obesity and Insulin Resistance, Not Polycystic Ovary Syndrome, Are Independent Predictors of Bone Mineral Density in Adolescents and Young Women
Pereira-Eshraghi, C., Chiuzan, C. C., Zhang, Y., Tao, R., McCann, M. R., Neugut, Y. D., Printz, A., Fennoy, I., Cree‐Green, M., Oberfield, S. E., et al. (2019) · Hormone Research in Paediatrics · doi:10.1159/000507079 · Cited by 11
Antral follicle count and anti-Müllerian hormone level as predictors of ovarian hyperstimulation syndrome in women with polycystic ovarian syndrome undergoing controlled ovarian stimulation
Izhar, R., Husain, S., Tahir, M. A., Kausar, M., Sana, T., Obstetrics and Gynaecology, D. A. G. R. I., & Ghalib, F. (2021) · Journal of Ultrasonography · doi:10.15557/jou.2021.0032 · Cited by 11
Vitamin B3 (niacin), B6, C, and iron intake are associated with the free androgen index, especially in normoandrogenic polycystic ovary syndrome
Brilliant, A., Astuti, B. P. K., Joyo, E. O., Febri, R. R., Silvana, V., & Muharam, R. (2022) · Journal of the Turkish-German Gynecological Association · doi:10.4274/jtgga.galenos.2022.2022-2-1 · Cited by 12
Linkage and association of variants in the dopamine receptor 2 gene (DRD2) with polycystic ovary syndrome
Amin, M., Horst, N., & Gragnoli, C. (2023) · Journal of Ovarian Research · doi:10.1186/s13048-023-01205-2 · Cited by 11
The impact of birth weight and maternal history on acne, hirsutism, and menstrual disorder symptoms in Turkish adolescent girls
Hızlı, D., Köşüş, A., Köşüş, N., Kamalak, Z., Ak, D., & Turhan, N. Ö. (2011) · Endocrine · doi:10.1007/s12020-011-9575-x · Cited by 11
Melatonin vs. phytomelatonin: Therapeutic uses with special reference to polycystic ovarian syndrome (PCOS)
Basheer, M., & Rai, S. (2016) · Cogent Biology · doi:10.1080/23312025.2015.1136257 · Cited by 11
Hormonal characteristics of women with clinical features of the polycystic ovary syndrome
Heineman, M. J., Thomas, C. M. G., Doesburg, W. H., & Rolland, R. (1984) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/0028-2243(84)90069-8 · Cited by 11
Elevation of isoprostanes in polycystic ovary syndrome and its relationship with cardiovascular risk factors
Calzada, M. J., López, N., Velasco, J. A. N., Mendiola, J., & Torres-Cantero, A. M. (2018) · Journal of Endocrinological Investigation · doi:10.1007/s40618-018-0888-y · Cited by 10
Hypersecretion of basal luteinizing hormone and an increased risk of pregnancy loss among women with polycystic ovary syndrome undergoing controlled ovarian stimulation and intrauterine insemination
Wang, B., & Li, Z. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e16233 · Cited by 10
The impact of polycystic ovary syndrome on placental histopathology patterns in in-vitro fertilization singleton live births
Hochberg, A., Mills, G., Volodarsky‐Perel, A., Nu, T. N. T., Machado-Gédéon, A., Cui, Y., Shaul, J., & Dahan, M. H. (2023) · Placenta · doi:10.1016/j.placenta.2023.05.015 · Cited by 11
The function of exosomes in ovarian granulosa cells
Zhou, R., & Liu, D. (2023) · Cell and Tissue Research · doi:10.1007/s00441-023-03820-3 · Cited by 10
White-brown adipose tissue interplay in polycystic ovary syndrome: Therapeutic avenues
Abbasi, K., Zarezadeh, R., Valizadeh, A., Mehdizadeh, A., Hamishehkar, H., Nouri, M., & Darabi, M. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.116012 · Cited by 12
Clinical manifestations of polycystic ovary syndrome
Sparić, R., Zlatar, J., Nikolić, L., Opalić-Palibrk, M., Radić, L., Bjekić-Macut, J., Ognjanovic, S. I., & Μacut, D. (2024) · Medicinska istrazivanja · doi:10.5937/medi57-52718 · Cited by 10
Clinical Assessment of People With Obesity: Focus on Adiposity-Related Multimorbidity
Bianchettin, R. G., Gawey, B. J., Acosta, A. J., Borlaug, B. A., Caples, S. M., Collazo–Clavell, M. L., Clark, M. M., Lara-Breitinger, K. M., Lerman, A., Lerman, L. O., et al. (2025) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2025.02.021 · Cited by 13
Female Sexual Dysfunction and Schizophrenia: A Clinical Review
Lodha, P., & Sousa, A. D. (2020) · Journal of Psychosexual Health · doi:10.1177/2631831820916096 · Cited by 10
Therapeutic potentials of the caffeine in polycystic ovary syndrome in a rat model
Raoofi, A., Rezaie, M. J., Delbari, A., Ghoreishi, S. A.-H., Sichani, P. H., Maleki, S., Nasiry, D., Akhlaghi, M., Ebrahimi, V., & Khaneghah, A. M. (2022) · Allergologia et Immunopathologia · doi:10.15586/aei.v50i6.715 · Cited by 11
Congenital Adrenal Hyperplasia, Polycystic Ovary Syndrome and criminal behavior: A Swedish population based study
Gotby, A. O., Nordenström, A., Falhammar, H., Nordenskjöld, A., Hirschberg, A. L., Frisén, L., Landén, M., & Lichtenstein, P. (2015) · Psychiatry Research · doi:10.1016/j.psychres.2015.07.008 · Cited by 10
Longitudinal Anti-Müllerian Hormone in Women with Polycystic Ovary Syndrome: An Acupuncture Randomized Clinical Trial
Franasiak, J. M., Young, S. L., Williams, C. D., & Pastore, L. M. (2012) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2012/973712 · Cited by 10
Plasma Von Willebrand factor antigen levels are elevated in the classic phenotypes of polycystic ovary syndrome
Koiou, E., Τζιόμαλος, Κ., Katsikis, I., Dinas, K. D., Tsourdi, E. A., Kandaraki, E., Delkos, D., Papadakis, E. P., & Panidis, D. (2012) · HORMONES · doi:10.1007/bf03401540 · Cited by 10
Gene Polymorphisms in Female Reproduction
Casarini, L., & Simoni, M. (2014) · Methods in molecular biology · doi:10.1007/978-1-4939-0659-8_4 · Cited by 10
Relationship between Vitamin D and Insulin Resistance in Polycystic Ovary Syndrome Women
Singh, S., Agrawal, P. K., Garg, R., & Kokila, B. N. (2017) · Journal of South Asian Federation of Obstetrics and Gynaecology · doi:10.5005/jp-journals-10006-1497 · Cited by 10
Effects of metabolic abnormalities, hyperandrogenemia and clomiphene on liver function parameters among Chinese women with polycystic ovary syndrome: results from a randomized controlled trial
Cai, W.-Y., Gao, J., Luo, X., Ma, H., Ge, H., Liu, N., Xia, Q., Wang, Y., Han, B.-W., & Wu, X. (2018) · Journal of Endocrinological Investigation · doi:10.1007/s40618-018-0953-6 · Cited by 10
Polycystic ovary syndrome and offspring risk of congenital heart defects: a nationwide cohort study
Schmidt, A. B., Lund, M., Wohlfahrt, J., & Melbye, M. (2020) · Human Reproduction · doi:10.1093/humrep/deaa168 · Cited by 10
Excess of ovarian nerve growth factor impairs embryonic development and causes reproductive and metabolic dysfunction in adult female mice
Manti, M., Pui, H., Edström, S., Risal, S., Lu, H., Lindgren, E., Ohlsson, C., Jerlhag, E., Benrick, A., Deng, Q., et al. (2020) · The FASEB Journal · doi:10.1096/fj.202001060r · Cited by 10
Anti-Müllerian hormone as a driving force of polycystic ovary syndrome, independently from insulin resistance
Robin, G., Deknuydt, M., Barbotin, A., Pigny, P., Catteau-Jonard, S., & Dewailly, D. (2021) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2021.01.012 · Cited by 10
Self-citation
Probiotics supplementation for management of type II diabetes risk factors in adults with polycystic ovarian syndrome: a meta-analysis of randomized clinical trial
Zhang, C., Sheng, Y., Jiang, J., Xue, Y., Yu, L., Tian, F., Zhao, J., Zhang, H., Jin, J., & Zhai, Q. (2022) · Food Science and Human Wellness · doi:10.1016/j.fshw.2022.10.023 · Cited by 10
Recent Advances in Acne Vulgaris Research: Insights and Clinical Implications
Wang, K., & Zane, L. T. (2008) · Advances in Dermatology · doi:10.1016/j.yadr.2008.09.002 · Cited by 10
Evidence of biochemical hyperandrogenism in women: The limitations of serum testosterone quantitation
Bell, A., Meek, C. L., & Viljoen, A. (2012) · Journal of Obstetrics and Gynaecology · doi:10.3109/01443615.2012.656741 · Cited by 10
Determinants of gestational diabetes mellitus: a hospital-based case–control study in coastal South India
Ganapathy, A., Holla, R., Darshan, B. B., Kumar, N., Kulkarni, V., Unnikrishnan, B., Thapar, R., Mithra, P., & Kumar, A. (2020) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-020-00844-1 · Cited by 11
A case-control study of polychlorinated biphenyl association with metabolic and hormonal outcomes in polycystic ovary syndrome
Brennan, E., Kumar, N., Drage, D. S., Cunningham, T. K., Sathyapalan, T., Mueller, J. F., & Atkin, S. L. (2022) · Journal of Environmental Science and Health Part C · doi:10.1080/26896583.2022.2043135 · Cited by 9
Integrated bioinformatics analysis elucidates granulosa cell whole-transcriptome landscape of PCOS in China
Li, Q., Sang, Y., Chen, Q., Ye, B., Zhou, X., & Zhu, Y. (2023) · Journal of Ovarian Research · doi:10.1186/s13048-023-01223-0 · Cited by 12
Exploring the benefits of astaxanthin as a functional food ingredient: Its effects on oxidative stress and reproductive outcomes in women with PCOS – A systematic review and single-arm meta-analysis of randomized clinical trials
Rodrigues, V. D., Boaro, B. L., Laurindo, L. F., Chagas, E. F. B., de Lima, E. P., Laurindo, L. F., & Barbalho, S. M. (2024) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-024-03432-w · Cited by 10
Analyzing and evaluating the metabolic and endocrine characteristics between lean and obese patients with polycystic ovary syndrome: a systemic review and meta-analysis
Zheng, C., Lin, Y., Zhang, Z., Ye, J., Lin, Y., & Tian, J. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1680685 · Cited by 10
The casein kinase 2α promotes the occurrence polycystic ovary syndrome
Yu, C., Liu, X., Zhou, Z., Chen, X., Meng, Y.-C., Gu, H., Xu, J.-J., Ding, G., Liu, X., Sheng, J., et al. (2020) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2020.02.065 · Cited by 9
The Effect of Exercise Training on Body Composition, Insulin Resistance and High Sensitivity C-reactive Protein (Hs-CRP) in Women With Polycystic Ovary Syndrome: A Pilot Study From North India
Pandit, U., Singh, M., Ranjan, R., & Gupta, V. (2022) · Cureus · doi:10.7759/cureus.23994 · Cited by 11
A review on inflammation and angiogenesis as key mechanisms involved in the pathogenesis of bovine cystic ovarian disease
Stassi, A. F., Díaz, P. U., Gasser, F. B., Velázquez, M. M. L., Gareis, N. C., Salvetti, N. R., Ortega, H. H., & Baravalle, M. E. (2022) · Theriogenology · doi:10.1016/j.theriogenology.2022.04.002 · Cited by 9
The ADMA–DDAH1 axis in ovarian apoptosis of polycystic ovary syndrome
Li, T., Zhang, T., Wang, H., Zhang, Q., Gao, H., Liu, R., & Yin, C. (2022) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2022.106180 · Cited by 9
Establishment and Analysis of an Artificial Neural Network Model for Early Detection of Polycystic Ovary Syndrome Using Machine Learning Techniques
Wu, Y., Xiao, Q., Wang, S., Xu, H., & Fang, Y. (2023) · Journal of Inflammation Research · doi:10.2147/jir.s438838 · Cited by 9
Effects of gonadotropin-releasing hormone agonist and antagonist on ovarian activity in a mouse model for polycystic ovary
Singh, P., Srivastava, R. K., & Krishna, A. (2016) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2016.03.034 · Cited by 9
Whole Genome Sequencing instead of Whole Exome Sequencing is required to identify the Genetic Causes of Polycystic Ovary Syndrome in Pakistani families
Khan, M. J., Nazli, R., Ahmed, J., & Basit, S. (2018) · Pakistan Journal of Medical Sciences · doi:10.12669/pjms.343.14644 · Cited by 9
Metformin: A stroke of luck
Aljofan, M., & Gaipov, A. (2019) · Electronic Journal of General Medicine · doi:10.29333/ejgm/108679 · Cited by 9
Comparison of clinical, metabolic, hormonal, and ultrasound parameters among the clomiphene citrate-resistant and clomiphene citrate-sensitive polycystic ovary syndrome women
Gainder, S., Sachdeva, G., Suri, V., Sachdeva, N. K., & Chopra, S. (2019) · Journal of Human Reproductive Sciences · doi:10.4103/jhrs.jhrs_89_18 · Cited by 9
The function of BAP18 on modulation of androgen receptor action in luteinized granulosa cells from normal weight women with and without PCOS
Tang, T., Jiao, J., Li, D., Sun, G., Lin, L., Wang, C., Wang, S., Zou, R., Liu, W., Zhao, Y., et al. (2021) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2021.111228 · Cited by 9
Vitamin D deficiency effects on cardiovascular parameters in women with polycystic ovary syndrome: A retrospective, cross-sectional study
Butler, A. E., Dargham, S. R., Abouseif, A., Elshewehy, A. M. M., & Atkin, S. L. (2021) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2021.105892 · Cited by 9
Polycystic Ovary Syndrome
Standeven, L. R., Hannan, K., Singh, B., & Hantsoo, L. V. (2023) · Advances in Psychiatry and Behavioral Health · doi:10.1016/j.ypsc.2023.03.014 · Cited by 9
Are serum gamma-glutamyl transferase, high-sensitivity C-reactive protein, and ischaemia-modified albumin useful in diagnosing PCOS?
Ozturk, M., Keskin, U., Öztürk, Ö., Ulubay, M., Alanbay, İ., Aydin, A., & Yenen, M. C. (2016) · Journal of Obstetrics and Gynaecology · doi:10.1080/01443615.2016.1174827 · Cited by 9
Pay more attention to ethnic differences in polycystic ovary syndrome phenotypic expression
Qiao, J. (2013) · Chinese Medical Journal · doi:10.3760/cma.j.issn.0366-6999.20130650 · Cited by 9
Does insulin resistance increase thyroid volume in patients with polycystic ovary syndrome?
Şahin, M., Demircioğlu, D., Oğuz, A., Tüzün, D., Sarıca, M. A., İnanç, E., & Gül, K. (2016) · Archives of Endocrinology and Metabolism · doi:10.1590/2359-3997000000225 · Cited by 9
The Relationship Between Hearing Thresholds and Hyperandrogenism in Polycystic Ovary Syndrome
Turan, M., Üçler, R., Garça, M. F., Kurdoğlu, Z., Çankaya, H., Ayral, A., Bozan, N., Kıroğlu, A. F., & Kurdoğlu, M. (2016) · Medical Science Monitor · doi:10.12659/msm.898670 · Cited by 9
Prevalence of diminished ovarian reserve in Chinese women with polycystic ovary syndrome and sensitive diagnostic parameters
Jin, J., Ruan, X., Hua, L., Tian, X., Li, Y., Wang, L., & Mueck, A. O. (2017) · Gynecological Endocrinology · doi:10.1080/09513590.2017.1310838 · Cited by 9
The role of oligomenorrhea in melasma
Mahjour, M., Khoushabi, A., & Feyzabadi, Z. (2017) · Medical Hypotheses · doi:10.1016/j.mehy.2017.05.006 · Cited by 9
Prenatal Androgenization of Ewes as a Model of Hirsutism in Polycystic Ovary Syndrome
dos Santos, J. T., da Nóbrega, J. E., Mujica, L. K. S., Amaral, C. D. S., Machado, F. A., Manta, M. W., Rizzetti, T. M., Zanella, R., Fighera, R. A., Antoniazzi, A. Q., et al. (2018) · Endocrinology · doi:10.1210/en.2018-00781 · Cited by 9
The Possibilities of Using Chromium Salts as an Agent Supporting Treatment of Polycystic Ovary Syndrome
Piotrowska, A., Pilch, W., Czerwińska‐Ledwig, O., Zuziak, R., Siwek, A., Wolak, M., & Nowak, G. (2019) · Biological Trace Element Research · doi:10.1007/s12011-019-1654-5 · Cited by 9
Polycystic ovary syndrome
(2008) · Reproductive medicine and assisted reproductive techniques series · doi:10.3109/9781439807224.008 · Cited by 9
Immune dysfunction mediated by the competitive endogenous RNA network in fetal side placental tissue of polycystic ovary syndrome
Xie, N., Wang, F., Chen, D., Zhou, J., Xu, J., & Qu, F. (2024) · PLoS ONE · doi:10.1371/journal.pone.0300461 · Cited by 8
SIRT2-dependent DKK1 deacetylation aggravates polycystic ovary syndrome by targeting the TGF-β1/Smad3 signaling pathway
Chen, L., & Kong, C. (2024) · Gynecological Endocrinology · doi:10.1080/09513590.2024.2353733 · Cited by 8
Research trends and hotspots of acupuncture therapy for obesity from 2004 to 2023: A bibliometric analysis
Wang, J., Cao, K., Chen, Z., Lyu, T., Xia, Q., Liu, L., & Li, B. (2024) · Complementary Therapies in Medicine · doi:10.1016/j.ctim.2024.103092 · Cited by 8
COVID-19 and persistent symptoms: implications for polycystic ovary syndrome and its management
Zhang, S., Wu, Y., Mprah, R., & Wang, M. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1434331 · Cited by 8
Comparative efficacy of combined myo-inositol and D-chiro inositol versus metformin across PCOS Phenotypes: enhancing ovarian function, ovulation, and stress response in a prospective clinical trial
Gul, M., Khan, H., Rauf, B., Bukhari, S. M. S., Ehtesham, E., Malik, M. O., Shah, F. A., Alanazi, F. E., & Shah, M. (2025) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-025-03813-9 · Cited by 8
Polycystic Ovarian Syndrome and Female Infertility
Naqvi, S. M. A. S., Bhattarai, J. B., Li, H., & Wang, X. W. (2019) · Yangtze Medicine · doi:10.4236/ym.2020.41002 · Cited by 9
A PPARG Splice Variant in Granulosa Cells Is Associated with Polycystic Ovary Syndrome
Shi, C.-Y., Xu, J.-J., Li, C., Yu, J., Wu, Y., & Huang, H. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11247285 · Cited by 8
Comprehensive Management of Polycystic Ovary Syndrome: Effect of Pharmacotherapy, Lifestyle Modification, and Enhanced Adherence Counseling
Jungari, M. L., Choudhary, A., & Gill, N. K. (2023) · Cureus · doi:10.7759/cureus.35415 · Cited by 12
Causal association between low vitamin D and polycystic ovary syndrome: a bidirectional mendelian randomization study
Gao, B., Zhang, C., Wang, D., Li, B.-J., Shan, Z., Teng, W., & Li, J. (2024) · Journal of Ovarian Research · doi:10.1186/s13048-024-01420-5 · Cited by 10
The Beneficial Effects of Lacticaseibacillus paracasei subsp. paracasei DSM 27449 in a Letrozole-Induced Polycystic Ovary Syndrome Rat Model
Lee, Y. Z., Cheng, S.-H., Lin, Y., Wu, C.-C., & Tsai, Y.-C. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25168706 · Cited by 8
A metabolome-wide Mendelian randomization study prioritizes causal circulating metabolites for reproductive disorders including primary ovarian insufficiency, polycystic ovary syndrome, and abnormal spermatozoa
Chen, S., Sun, S., Cai, M., Zhou, Z., Ma, Y., Zhou, Z., Wang, F., Liu, J., Song, W., Liu, Y., et al. (2024) · Journal of Ovarian Research · doi:10.1186/s13048-024-01486-1 · Cited by 8
Mechanism underlying the retarded nuclear translocation of androgen receptor splice variants
Liu, Y., Wang, Y., Wang, F., Pan, J., Xu, J.-J., Li, J., Zhou, C., Ding, G., Wu, Y., Liu, X., et al. (2018) · Science China Life Sciences · doi:10.1007/s11427-018-9379-x · Cited by 8
Evaluation of Carotid Artery Intima-Media Thickness as a Cardiovascular Risk Factor in Patients With Polycystic Ovary Syndrome
Bahat, P. Y., Özel, A., & Demirci, A. (2021) · Cureus · doi:10.7759/cureus.13025 · Cited by 8
Hospital-Based Phenotypic Features and Treatment Outcomes of Chinese Women with Polycystic Ovary Syndrome: The Effect of Body Mass Index and Geographic Distribution
Gao, J., Ma, H., Wang, Y., Yang, X., Cao, Y., Zhang, B., Han, C., & Wu, X. (2021) · Engineering · doi:10.1016/j.eng.2020.12.006 · Cited by 8
Reproductive Health in First-degree Relatives of Patients With Polycystic Ovary Syndrome: A Review and Meta-analysis
Shan, D., Han, J., Cai, Y., Zou, L., Xu, L., & Shen, Y. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab640 · Cited by 8
Ovarian follicle count by magnetic resonance imaging is greater in adolescents and young adults with polycystic ovary syndrome than in controls
Pereira-Eshraghi, C., Tao, R., Chiuzan, C. C., Zhang, Y., Shen, W., Lerner, J. P., Oberfield, S. E., & Sopher, A. B. (2022) · F&S Reports · doi:10.1016/j.xfre.2022.01.008 · Cited by 8
CTBP1‑AS upregulation is associated with polycystic ovary syndrome and can be effectively downregulated by cryptotanshinone
Wen, M., Dou, X., Zhang, S., Wang, B., Xu, J., Zhang, W., & Wang, F. (2022) · Molecular Medicine Reports · doi:10.3892/mmr.2022.12761 · Cited by 8
Investigating the active components of Huatan Tongjing decoction for the treatment of polycystic ovary syndrome via network pharmacology
Yu, J., Fu, Y., Zeng, L., & Zheng, Y. (2022) · Chemical Biology & Drug Design · doi:10.1111/cbdd.14117 · Cited by 8
Screening target genes for the treatment of PCOS via analysis of single-cell sequencing data
Lu, Z., Chen, C., Gao, Y., Li, Y., Zhao, X., Zhang, H., Wei, Q., Zeng, X., Li, Y., & Wan, M. (2022) · Annals of Medicine · doi:10.1080/07853890.2022.2136401 · Cited by 8
Sex Differences in the Association Between Serum Testosterone and Kidney Function in the General Population
van der Burgh, A. C., Aribas, E., Ikram, M. A., Kavousi, M., Neggers, S. J. C. M. M., Hoorn, E. J., & Chaker, L. (2023) · Kidney International Reports · doi:10.1016/j.ekir.2023.04.015 · Cited by 8
Déficits en 21-hydroxylase et infertilité féminine : de la physiopathologie à la prise en charge thérapeutique
Robin, G., Decanter, C., Baffet, H., Catteau-Jonard, S., & Dewailly, D. (2014) · Gynécologie Obstétrique & Fertilité · doi:10.1016/j.gyobfe.2014.04.005 · Cited by 8
Self-citation
No association of the G972S polymorphism of the insulin receptor substrate-1 gene with polycystic ovary syndrome in lean PCOS women with biochemical hyperandrogenemia
Marioli, D. J., Koika, V., Adonakis, G. L., Saltamavros, A. D., Karela, A., Armeni, A. K., Tsapanos, V., Decavalas, G., & Georgopoulos, N. A. (2009) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-009-1299-2 · Cited by 8
Effects of Pioglitazone on Menstrual Frequency, Hyperandrogenism and Insulin Resistance in Adoloscents and Young Adults with Polycystic Ovary Syndrome
Rao, L. N., Jacob, J. J., Paul, T. V., Rajarathinam, S., Thomas, N., & Seshadri, M. S. (2009) · Journal of Pediatric and Adolescent Gynecology · doi:10.1016/j.jpag.2008.08.005 · Cited by 8
Metabolic syndrome in young women with the polycystic ovary syndrome: revisiting the threshold for an abnormally decreased high‐density lipoprotein cholesterol serum level
Dewailly, D., Contestin, M., Gallo, C., & Catteau-Jonard, S. (2009) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2009.02386.x · Cited by 8
Self-citation
Impact of weight loss on plasma ghrelin level, clinical, and metabolic features of obese women with or without polycystic ovary syndrome
Rashad, N. M., Saraya, Y. S., Afifi, S. A., Ali, A. E., & Al-sayed, R. M. (2019) · Middle East Fertility Society Journal · doi:10.1186/s43043-019-0006-x · Cited by 8
Maternal Overweight vs. Polycystic Ovary Syndrome: Disentangling Their Impact on Insulin Action in Pregnancy—A Prospective Study
Feichtinger, M., Linder, T., Rosicky, I., Eppel, D., Schatten, C., Eppel, W., Husslein, P. W., Tura, A., & Göbl, C. S. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm10010035 · Cited by 8
Polycystic Ovary Syndrome
Paschou, S. Α., Goulis, D. G., & Tarlatzis, B. C. (2019) · ISGE series · doi:10.1007/978-3-030-14358-9_5 · Cited by 8
The relationship of urocortin-2 with insulin resistance patients having PCOS
Temür, M., Yılmaz, Ö., Aksun, S., Çalan, M., Özbay, P. Ö., Kumbasar, S., & Sever, E. (2016) · Gynecological Endocrinology · doi:10.1080/09513590.2016.1240772 · Cited by 8
Evaluation of Ki-67 antigen expression in the zona reticularis of the adrenal cortex of female rats in persistent estrus
da Silva, B. B., Lopes‐Costa, P. V., dos Santos, A. R., Pires, C. G., Borges, C. S., & Gontijo, J. A. R. (2008) · Human Reproduction · doi:10.1093/humrep/den451 · Cited by 9
Assessment of the retinal and choroidal microvascularization in polycystic ovary syndrome: an optical coherence tomography angiography study
Açar, Ö. P. A., Cengiz, H., Onur, İ. U., Ilıman, D. E., Zırtıloğlu, S., & Yiğit, F. U. (2021) · International Ophthalmology · doi:10.1007/s10792-021-01787-0 · Cited by 7
Prevalence and correlates of diagnosed and probable polycystic ovary syndrome (PCOS) in a cohort of parous women
Perng, W., Fitz, V. W., Salmon, K., Hivert, M., Kazemi, M., Rifas‐Shiman, S. L., Shifren, J. L., Oken, E., & Chavarro, J. E. (2024) · American Journal of Epidemiology · doi:10.1093/aje/kwae179 · Cited by 7
New insights into the relationship of antimüllerian hormone with polycystic ovary syndrome and its diagnostic accuracy: an updated and extended meta-analysis using a marginal beta-binomial model
Barghi, M., Heidari, Z., Haghighatdoost, F., Feizi, A., & Hashemipour, M. (2024) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2024.10.004 · Cited by 9
Spotlight on Proteases: Roles in Ovarian Health and Disease
Kushawaha, B., & Pelosi, E. (2025) · Cells · doi:10.3390/cells14120921 · Cited by 7

Authors: Norman, R. J., Dewailly, D., Legro, R. S., & Hickey, T. E.
Affiliations: The University of Adelaide (AU)
Centre Hospitalier Universitaire de Lille (FR)
Pennsylvania State University (US)
Corresponding author: Hickey, Theresa E
ORCID: Norman, Robert J
Dewailly, Didier
Legro, Richard S
Hickey, Theresa E
Venue: The Lancet
Publisher: Elsevier BV
Published: 2007-08
Volume: 370
Issue: 9588
Pages: 685-697
ISSN: 0099-5355 (ISSN-L)
0140-6736
DOI: 10.1016/s0140-6736(07)61345-2
OpenAlex: W2499178053
Cited by: 1,360
References: 181
Citations by year: 2026: 43 · 2025: 61 · 2024: 100 · 2023: 100 · 2022: 101 · 2021: 105 · 2020: 94 · 2019: 86 · 2018: 86 · 2017: 74 · 2016: 78 · 2015: 70 · 2014: 62 · 2013: 52 · 2012: 60
FWCI: 6.99
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: The Lancet (publishedVersion)
Adelaide Research & Scholarship (AR&S) (University of Adelaide) (submittedVersion)
Topics: Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic and Kidney Cyst Diseases
Keywords: polycystic ovary syndrome, hyperandrogenism, insulin resistance, menstrual disorders, infertility, hirsutism, acne, obesity, metabolic syndrome, type 2 diabetes, cardiovascular disease, diagnostic criteria, chronic anovulation, polycystic ovary, genetic susceptibility, lifestyle factors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Polycystic ovary syndrome

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks